BSM(300796)

Search documents
贝斯美:贝斯美业绩说明会、路演活动信息
2023-03-20 08:17
证券代码: 300796 证券简称:贝斯美 编号:2023-001 绍兴贝斯美化工股份有限公司投资者关系活动记录表 感谢您的关注! | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | | --- | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | | □ 新闻发布会 □ 路演活动 | | | | 现场参观 □ | | | | 其他 (请文字说明其他活动内容) □ | | | 参与单位名称及 | 投资者网上提问 | | | 人员姓名 | | | | 时间 | 年 月 日 2023 3 (周五) 下午 15:00~17:00 | 17 | | 地点 | 公司通过全景网"投资者关系互动平台"(https://ir.p5w.net) | | | | 采用网络远程的方式召开业绩说明会 | | | 上市公司接待人 | 1、贝斯美董事长陈峰 | | | 员姓名 | 2、贝斯美董事、总经理钟锡君 | | | | 3、贝斯美财务总监屠汶君 | | | | 4、董事会秘书张校乾 | | | | 5、独立董事方咏梅 | | | | 6、保荐代表人戴菲 | | | 投资者关系活动 | 投资 ...
贝斯美(300796) - 2022 Q4 - 年度财报
2023-03-07 16:00
Financial Performance - The company's operating revenue for 2022 was ¥768,072,342.96, representing a 44.91% increase compared to ¥530,016,289.44 in 2021[24]. - Net profit attributable to shareholders for 2022 was ¥152,884,832.89, a significant increase of 171.10% from ¥56,393,722.60 in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥156,414,033.56, up 171.15% from ¥57,684,802.87 in the previous year[24]. - The total assets at the end of 2022 reached ¥2,100,743,391.28, marking a 50.25% increase from ¥1,398,208,062.65 at the end of 2021[24]. - The basic earnings per share for 2022 was ¥0.79, reflecting a 132.35% increase compared to ¥0.34 in 2021[24]. - The cash flow from operating activities for 2022 was ¥186,518,934.28, which is a 95.01% increase from ¥95,647,029.55 in 2021[24]. - The company reported a quarterly revenue of ¥221,591,607.95 in Q4 2022, the highest among the four quarters[26]. - In 2022, the company achieved a sales revenue of 768 million yuan, representing a year-on-year increase of 45%[64]. - The net profit attributable to shareholders reached 153 million yuan, a significant year-on-year growth of 171%[64]. - The revenue from the main product, dimethyl sulfoxide (DMS), was ¥614,612,307.50, accounting for 80.02% of total revenue, with a year-on-year growth of 54.01%[72]. - Revenue from international markets was ¥490,503,771.32, representing 63.86% of total revenue, with a significant increase of 72.72% compared to ¥283,990,257.00 in 2021[72]. - Direct sales accounted for 97.44% of total revenue at ¥748,447,564.97, showing a year-on-year increase of 57.60%[72]. - Gross profit margin for the main product DMS was 40.15%, up from 32.71% in the previous year, indicating improved profitability[75]. - The sales volume of DMS increased by 20.47% to 11,020.49 tons in 2022, compared to 9,147.77 tons in 2021[77]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 1.2 CNY per 10 shares to all shareholders, based on a total of 200,634,929 shares[3]. - The company held three temporary shareholder meetings in 2022, with investor participation rates of 49.98%, 42.24%, and 41.40% respectively[163]. - The annual shareholder meeting in 2021 had a participation rate of 49.97%[163]. - The company reported a total of 536,900 shares held by directors at the end of the reporting period, with an increase of 153,400 shares during the period[166]. Risk Management - The company faces several risks including market growth below expectations, high customer concentration, and fluctuations in tax incentives and exchange rates[3]. - The company emphasizes the importance of risk awareness among investors regarding forward-looking statements and future plans[3]. - The company has detailed its future development outlook and risk management strategies in the management discussion section of the report[3]. Research and Development - The company is actively enhancing its R&D capabilities to address the need for optimization in domestic pesticide production processes[43]. - The company holds 53 authorized patents, including 23 invention patents and 30 utility model patents, reflecting its strong R&D capabilities[56]. - The company is currently developing new pesticide varieties and carbon five new material products, laying a solid foundation for future growth[56]. - The company is focused on integrating its operations across the entire industrial chain, enhancing its overall competitiveness compared to single-segment pesticide manufacturers[55]. - The company has established partnerships with universities and research institutions to enhance its R&D efforts[56]. - The company is developing new products and technologies, including the synthesis of herbicide intermediates and optimization of existing processes to enhance market competitiveness[86]. Market and Industry Trends - The global crop protection market is projected to reach $66.703 billion in 2023, with a compound annual growth rate of 3% from 2018 to 2023[36]. - The company operates in a highly concentrated global pesticide market, which is expected to provide growth opportunities for leading raw material enterprises[37]. - The domestic pesticide industry is undergoing significant transformation, with a strong demand for green pesticides and a rapid phase-out of high-toxicity products[41]. - The pesticide market is shifting towards high-efficiency, low-toxicity, and low-residue products, driven by stricter environmental regulations[41]. - The global pesticide market sales increased from $25.15 billion in 2002 to $62.04 billion in 2020, indicating a growing market[127]. - By 2030, the global population is expected to reach 8.5 billion, increasing the demand for food and consequently for pesticides[128]. Corporate Governance - The company strictly adheres to laws and regulations, ensuring compliance with corporate governance standards as of the end of the reporting period[147]. - The board of directors consists of 9 members, including 3 independent directors, meeting legal requirements[149]. - The company has established a compensation mechanism linking salaries to company performance and individual achievements to attract and retain talent[152]. - The company maintains complete independence in operations, assets, and financial matters from its controlling shareholders and related parties[156]. - The company has a fully independent financial accounting department, capable of making independent financial decisions[162]. - The company has a governance structure that includes a mix of independent and non-independent directors[165]. - The company has a total of 10 directors and supervisors, with 6 receiving remuneration from the company[186]. Environmental and Safety Management - The company emphasizes green and environmentally friendly production processes, aiming to reduce waste emissions while increasing output[56]. - The company has a valid safety production license until July 16, 2024[50]. - The company is actively applying for and obtaining environmental impact assessments for new projects[49]. - The company has a valid pollutant discharge permit until December 31, 2025[50]. - The company will continue to enhance safety and environmental management to ensure stable and orderly production operations[142]. Employee and Talent Management - The company has established a performance-based compensation system that includes basic salary, performance bonuses, allowances, and overtime pay[199]. - The company will continue to improve its compensation system to enhance employee recognition and belonging, ensuring a talent pool for long-term development[199]. - In 2023, the company will focus on targeted, effective, and practical training to improve management skills and employee competencies[200]. - The company’s management team includes a diverse group of individuals with varying ages and backgrounds[165]. - The company has a total of 492 employees at the end of the reporting period, with 208 in the parent company and 284 in major subsidiaries[197].
贝斯美:关于举行2022年度业绩说明会的公告
2023-03-07 09:10
证券代码:300796 证券简称:贝斯美 公告编号:2023-007 绍兴贝斯美化工股份有限公司 关于举行2022年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 绍兴贝斯美化工股份有限公司(以下简称"公司")《2022年年度报告》全 文及其摘要已于2023年3月8日在巨潮资讯网 (www.cninfo.com.cn)上披露,并 于同日在《中国证券报》、《证券时报》、《上海证券报》、《证券日报》上刊登了提 示性公告。为便于投资者能够进一步了解公司的生产经营情况,公司定于2023 年3月17日(周五)15:00-17:00在全景网举办2022年度业绩说明会,本次年度业 绩说明会将采用网络远程的方式举行,投资者可登陆全景网"投资者关系互动平 台"(https://ir.p5w.net)参与本次年度业绩说明会或者直接进入绍兴贝斯美 化工股份有限公司路演厅(https://ir.p5w.net/c/300796.shtml)参与本次年 度业绩说明会。 出席本次说明会的人员有:公司董事长陈峰先生、董事兼总经理钟锡君先生、 独立董事方咏梅女士、董事会秘 ...
贝斯美(300796) - 2022 Q3 - 季度财报
2022-10-20 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥174,191,268.39, representing a 110.89% increase year-over-year[5] - Net profit attributable to shareholders was ¥40,102,671.57, a significant increase of 512.03% compared to the same period last year[5] - The basic earnings per share for the quarter was ¥0.2, reflecting a 300.00% increase year-over-year[5] - Total operating revenue for Q3 2022 reached ¥546,480,735.01, a significant increase of 52.5% compared to ¥358,564,276.03 in Q3 2021[22] - Net profit for Q3 2022 was ¥117,959,518.54, representing a 164.5% increase from ¥44,662,538.83 in Q3 2021[23] - Basic and diluted earnings per share were both CNY 0.6, compared to CNY 0.36 in the previous year, reflecting a 66.67% increase[24] - The total comprehensive income for the third quarter was CNY 117,959,518.54, an increase from CNY 44,662,538.83 in the same period last year[24] Assets and Liabilities - Total assets as of September 30, 2022, amounted to ¥1,932,484,855.29, a 38.21% increase from the end of the previous year[5] - The company's total assets increased to ¥1,932,484,855.29, compared to ¥1,398,208,062.65 at the end of Q3 2021, reflecting a growth of 38.2%[20] - Current liabilities totaled ¥214,795,636.21, a decrease of 24.1% from ¥282,759,693.98 in the previous year[20] - The total liabilities of the company were ¥339,402,788.24, which is an increase from ¥309,120,454.98 in the previous year, indicating a growth of 9.3%[20] - The company’s total liabilities decreased by 39.46% for current non-current liabilities due within one year[9] Cash Flow - The company reported a net cash flow from operating activities of ¥167,096,906.18, which is a 192.55% increase year-to-date[5] - Net cash flow from operating activities was CNY 167,096,906.18, significantly up from CNY 57,117,565.03 in the prior year, marking a 192.56% increase[26] - Cash received from sales of goods and services was CNY 436,307,427.83, compared to CNY 343,633,734.94 in the same period last year, representing a 27.00% increase[25] - The company reported a significant increase in cash received from customers, with a total of CNY 552,606,247.45 in operating cash inflows, up from CNY 365,606,029.86[25] - The company incurred operating cash outflows totaling CNY 385,509,341.27, compared to CNY 308,488,464.83 in the previous year, reflecting a 24.99% increase[26] - Cash flow from financing activities generated a net inflow of CNY 423,935,208.29, compared to CNY 56,880,000.70 in the same period last year, indicating a substantial increase[26] - Investment activities resulted in a net cash outflow of CNY 151,915,100.65, an improvement from a net outflow of CNY 197,289,232.31 in the same period last year[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,198[13] - The largest shareholder, Ningbo Baismei Investment Holdings Co., Ltd., holds 23.02% of shares, amounting to 46,177,211 shares, with 22,960,000 shares pledged[13] - The company has no preferred shareholders as per the report[15] Investments and Subsidiaries - The company established a wholly-owned subsidiary, Baismei (Hefei) Technology Co., Ltd., with a registered capital of 5 million RMB on July 8, 2022[16] - The company plans to increase the capital of its subsidiary, Tongling Baismei Technology Co., Ltd., by 170 million RMB, raising its registered capital from 88 million RMB to 258 million RMB[17] - The company plans to continue expanding its market presence and investing in new projects, as indicated by a 102.14% increase in construction in progress[9] Research and Development - The company is engaged in various technology research and development activities, including new materials technology[16] - Research and development expenses for Q3 2022 were ¥26,875,017.29, up from ¥23,124,555.70 in Q3 2021, showing a growth of 12%[23] Other Financial Metrics - The gross profit margin improved significantly, with a profit total of ¥138,089,706.50 for the first nine months of 2022, up 177.78% from the previous year[11] - The company reported a financial income of ¥4,514,498.37, compared to ¥3,420,001.36 in the previous year, reflecting an increase of 32.1%[23] - Accounts receivable increased to 126,064,000.95 RMB from 83,898,279.02 RMB at the beginning of the year, indicating a growth of approximately 50%[18] - The company has a total of 54,384,308.69 RMB in accounts receivable financing as of September 30, 2022[18] Audit Information - The company did not conduct an audit for the third quarter report[27]
贝斯美(300796) - 2022 Q2 - 季度财报
2022-08-08 16:00
Financial Performance - The company reported a revenue of 500 million RMB for the first half of 2022, representing a year-on-year increase of 15%[19]. - The gross profit margin for the first half of 2022 was 30%, compared to 28% in the same period last year[19]. - The company's operating revenue for the reporting period was ¥372,289,466.62, representing a year-on-year increase of 34.90% compared to ¥275,965,224.14[26]. - Net profit attributable to shareholders was ¥74,746,021.37, marking a significant increase of 99.71% from ¥37,427,173.88 in the same period last year[26]. - The net profit after deducting non-recurring gains and losses was ¥71,543,993.17, up 94.87% from ¥36,713,123.35[26]. - The company achieved a sales revenue of 372 million yuan in the first half of 2022, representing a year-on-year growth of 34.90%[64]. - The net profit attributable to shareholders reached 74.75 million yuan, a significant increase of 99.71% compared to the previous year[64]. - The company's revenue for the reporting period reached ¥372,289,466.62, representing a year-on-year increase of 34.90% due to higher sales volume and product price increases[69]. - Operating costs amounted to ¥236,264,494.95, which is a 25.62% increase compared to the previous year[69]. Investment and Development - The company plans to invest 100 million RMB in new product development and technology research in the next fiscal year[19]. - R&D expenses amounted to 18.35 million yuan, reflecting a year-on-year increase of 17.48%[66]. - The company is actively constructing a project for producing 8,500 tons of ketone series green materials, with a financing amount of nearly 400 million yuan[66]. - The company has ongoing projects related to hydrogenation series and other chemical products, with significant investments planned for future growth[86]. - The company plans to use the unutilized funds for the original committed investment projects, ensuring compliance with investment commitments[95]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 25% market share by 2025[19]. - User data indicates a 20% increase in customer base, reaching 10,000 active users by June 30, 2022[19]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market presence[19]. - The company is actively exploring new overseas markets and clients, enhancing its export business through direct sales to pesticide manufacturers abroad[42]. - The company aims to leverage its existing customer base to drive future growth and enhance user engagement[101]. Environmental Commitment - The company emphasizes its commitment to environmental protection and sustainable practices in its operations[19]. - The company is committed to enhancing its production processes to reduce waste emissions and improve environmental standards[62]. - The company has implemented a comprehensive wastewater treatment system, ensuring effective collection and treatment of various wastewater types, which significantly reduces emissions[130]. - The company has installed VOC online monitoring devices for real-time monitoring of exhaust emissions, with data uploaded to the monitoring platform for timely adjustments[131]. - The company has developed an emergency response plan for environmental incidents, which has been filed with local environmental authorities[133]. Risk Management - The company faces risks including market growth below expectations and high customer concentration, which could impact future performance[3]. - The company’s revenue from the top five customers accounted for 61.05% of total revenue, indicating a high customer concentration risk[114]. - The company is actively seeking to diversify its customer base to reduce reliance on major clients and mitigate potential operational risks[114]. - The company’s risk control measures for foreign exchange transactions include strict adherence to internal regulations and only engaging with qualified financial institutions[106]. Shareholder and Financial Management - No cash dividends or stock bonuses will be distributed to shareholders for this period[4]. - The company has maintained a good relationship with investors, ensuring accurate and timely information disclosure to protect shareholder rights[136]. - The company has not distributed cash dividends or bonus shares for the half-year period, indicating a focus on reinvestment[125]. - The company has not engaged in any significant asset or equity sales during the reporting period, maintaining its asset base[108][109]. Foreign Exchange Management - The company is actively managing its foreign exchange risks through forward contracts[104]. - The foreign exchange rates have shown fluctuations, impacting the company's financial performance[104]. - The company has maintained a consistent settlement strategy to mitigate currency risk[104]. - The overall foreign exchange exposure is being closely monitored by the finance team[104]. Corporate Governance - The company has not reported any major changes or risks related to significant contracts during the reporting period[164]. - The company has not engaged in any major related party transactions during the reporting period[148]. - The company has not experienced any major litigation or arbitration matters during the reporting period[147]. - The company has not provided any external guarantees during the reporting period[144].
贝斯美(300796) - 2022 Q1 - 季度财报
2022-04-27 16:00
绍兴贝斯美化工股份有限公司 2022 年第一季度报告全文 证券代码:300796 证券简称:贝斯美 公告编号:2022-028 绍兴贝斯美化工股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明:保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 179,144,881.87 | 148,638,759.35 | 20.52% | | 归属于上市公司股东的净利润(元) | 30,943,310.64 | 24,29 ...
贝斯美(300796) - 2021 Q4 - 年度财报
2022-04-27 16:00
Financial Performance - The company's operating revenue for 2021 was ¥530,016,289.44, representing a 31.02% increase compared to ¥404,543,473.59 in 2020 [21]. - The net profit attributable to shareholders for 2021 was ¥56,393,722.60, a 46.81% increase from ¥38,411,515.91 in 2020 [21]. - The net profit after deducting non-recurring gains and losses was ¥57,684,802.87, up 66.07% from ¥34,734,808.17 in 2020 [21]. - The company's total assets at the end of 2021 were ¥1,398,208,062.65, a 7.04% increase from ¥1,306,233,986.18 at the end of 2020 [21]. - The basic earnings per share for 2021 was ¥0.47, a 46.88% increase compared to ¥0.32 in 2020 [21]. - The weighted average return on equity for 2021 was 5.40%, up from 3.77% in 2020 [21]. - The company reported a net cash flow from operating activities of ¥95,647,029.55, an 8.60% increase from ¥88,069,790.25 in 2020 [21]. - The total operating revenue for 2021 reached ¥530,016,289.44, representing a year-on-year increase of 31.02% compared to ¥404,543,473.59 in 2020 [78]. - The revenue from the main product, dimethyl sulfoxide raw material, accounted for ¥399,083,653.19, which is 75.30% of total revenue, showing a significant growth of 64.33% year-on-year [78]. - The gross profit margin for the main product category, including dimethyl sulfoxide raw material, improved to 30.55%, up from 27.39% in the previous year, reflecting a 3.16% increase [81]. - The company's overseas revenue constituted ¥283,990,257.00, which is 53.58% of total revenue, with a year-on-year growth of 29.24% [78]. - The production volume of dimethyl sulfoxide raw material increased by 47.36% year-on-year, reaching 9,662.38 tons, driven by strong market demand [85]. - The company reported a total revenue of 383.5 million in 2021, maintaining a stable financial performance compared to previous years [164]. Risk Factors - The company faced risks including market growth below expectations, high customer concentration, and fluctuations in tax incentives and exchange rates [6]. - The company emphasizes the importance of risk awareness among investors regarding forward-looking statements and future plans [6]. - The company has a high concentration of customers, which poses a risk to its operations [6]. - The company is facing potential risks from market growth not meeting expectations due to global economic adjustments affecting agricultural production expansion [142]. - The company is classified as a national high-tech enterprise, benefiting from a 15% corporate income tax rate, but faces risks if it fails to renew this status or if tax policies change [147]. Research and Development - The company emphasizes technological R&D, achieving production standards that meet or exceed those of developed countries, thus enhancing its competitiveness [42]. - The company has successfully developed low-cost synthesis processes for new high-quality pesticides, including Methoxyfenozide and Fluazifop-P-butyl, leveraging by-products from Dimethenamid-P [41]. - The company is currently developing new products, including Methoxyfenozide and Benzoylpropionic acid, to strengthen its future growth [65]. - The company has established partnerships with universities and research institutions, enhancing its R&D capabilities and innovation [65]. - The company has a total of 44 patents granted, reflecting its strong focus on technology research and development [65]. - The company plans to continue increasing R&D investment to enhance core competitiveness and mitigate the impact of potential changes in tax incentives [148]. Market Position and Strategy - The company is a leading enterprise in the niche field of Dimethenamid-P, possessing a complete production and R&D system across the entire industry chain [41]. - The company is positioned to become a qualified strategic supplier for multinational pesticide companies due to its cost advantages and comprehensive R&D capabilities [42]. - The company is actively exploring new markets and customers abroad, enhancing its international presence [54]. - The company aims to consolidate its leading position in the industry for its core products, particularly the herbicide Dimethenamid-P, through continuous process optimization and quality enhancement [139]. - The company plans to expand its product line by actively promoting the construction of green new material projects related to the Ketone series, enhancing its competitive advantage and market share [139]. - The company is focused on increasing its independent R&D capabilities to achieve a tiered product layout and promote the industrialization of new products such as Methoxyfenozide and Fluobenzamide [139]. Corporate Governance - The company has enhanced its corporate governance and transparency, improving communication with investors through various platforms [79]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance regulations [153]. - The company maintains independence from its controlling shareholder, ensuring that business operations are conducted autonomously [154]. - The company adheres to strict information disclosure practices, ensuring timely and fair access to information for all shareholders [156]. - The company has established a sound corporate governance structure with independent decision-making and supervisory bodies [159]. - The company has a clear governance structure with no mixed operations or shared offices with controlling shareholders [159]. Environmental and Social Responsibility - The company emphasizes safety production and has upgraded its environmental protection facilities to reduce pollutant emissions and energy consumption [75]. - The company is responding to increasing environmental regulations by focusing on the development of environmentally friendly pesticides, which provides significant market opportunities [136]. - The company has implemented a waste treatment system to comply with national and local emission standards [147]. - The company actively engages in charitable activities and fulfills social responsibilities, promoting sustainable development [156]. - The company is committed to improving its talent development mechanisms to ensure sustainable growth and enhance employee skills in safety and environmental protection [140]. Future Outlook - The company plans to raise up to 400 million RMB through a targeted stock issuance to support the "Annual Production of 8,500 Tons of Ketone Series Green New Materials Project" in Tongling, Anhui [75]. - The company has set a future outlook with a revenue target of 1.5 billion RMB for the next fiscal year, indicating an expected growth of 25% [169]. - The company is investing in new technology to improve production efficiency, aiming for a 20% reduction in production costs over the next two years [169]. - The management team has emphasized a commitment to sustainability, with plans to reduce carbon emissions by 30% by 2025 through innovative practices [169]. - The company plans to continue expanding its product range and optimizing its business structure to enhance profitability and sustainable growth [79].
贝斯美(300796) - 2021 Q3 - 季度财报
2021-10-26 16:00
绍兴贝斯美化工股份有限公司 2021 年第三季度报告 证券代码:300796 证券简称:贝斯美 公告编号:2021-079 绍兴贝斯美化工股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明:保证季度报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 82,599,051.89 | 16.06% | 358,564,276.03 | 42.75 ...
贝斯美(300796) - 2021 Q2 - 季度财报
2021-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥275,965,224.14, representing a 53.30% increase compared to ¥180,020,984.28 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached ¥37,427,173.88, a significant increase of 202.31% from ¥12,380,466.98 in the previous year[22]. - The net cash flow from operating activities was ¥87,317,316.14, marking a 381.80% increase compared to ¥18,123,257.31 in the same period last year[22]. - Basic earnings per share increased to ¥0.31, up 210.00% from ¥0.10 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥36,713,123.35, reflecting a 177.89% increase from ¥13,211,169.87 in the same period last year[22]. - The company reported a net profit of ¥714,050.53 from non-recurring gains and losses during the reporting period[26]. - The company achieved a sales revenue of 276 million CNY in the first half of 2021, representing a 53% year-on-year increase, with the main product, dimethenamid-P, seeing a significant revenue growth of 172%[56]. - The company reported a total profit of ¥43,108,673.55 for the first half of 2021, compared to ¥14,137,784.81 in the same period of 2020, reflecting a growth of 210.5%[183]. - The company’s tax expenses for the first half of 2021 were ¥5,077,866.45, compared to ¥2,083,800.34 in the first half of 2020, indicating an increase of 143.5%[183]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,305,315,385.98, a slight decrease of 0.07% from ¥1,306,233,986.18 at the end of the previous year[22]. - The total amount of restricted assets was CNY 147,225,626.82, primarily due to bank guarantees and pledged receivables[69]. - The total liabilities decreased to CNY 234,498,999.37 from CNY 268,359,714.40, a reduction of approximately 12.6%[175]. - The total current liabilities decreased to CNY 220,741,122.37 from CNY 268,228,464.40, a decline of about 17.7%[175]. - The cash and cash equivalents decreased to CNY 76,069,926.68 from CNY 183,946,455.07, a significant drop of about 58.7%[178]. Market Position and Strategy - The company is a leading enterprise in the Asia-Pacific region for the herbicide diquat, with a complete R&D and production system for its entire industrial chain[29]. - The company exports products to Europe, America, Pakistan, and India, and is actively exploring new markets in Australia and other Asian countries[39]. - The company has established stable supply relationships with overseas customers, selling directly to pesticide manufacturers for further processing[39]. - The company benefits from national industrial policies that support the development of environmentally friendly and low-toxicity pesticides, driving business growth[40]. - The company is positioned to benefit from the ongoing consolidation in the pesticide industry, which is expected to enhance its market share and customer base[43]. - The company is focused on digitalization, information technology, and smart management transformation to enhance operational efficiency and safety[57]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[89]. Research and Development - Research and development investment increased by 29.55% to 15.62 million CNY, reflecting the company's commitment to innovation[59]. - The company has 47 authorized patents, including 12 invention patents, enhancing its competitive edge in the pesticide industry[49]. - The company is actively developing new products, including methoxyfenozide and benzoylpropionic acid, to strengthen its market position[49]. - Investment in new product development has increased by 20% year-on-year, focusing on innovative chemical solutions to enhance market competitiveness[91]. Environmental and Social Responsibility - The company emphasizes environmental protection and has implemented a waste treatment system to comply with national standards[103]. - The company has a comprehensive wastewater treatment system, effectively reducing wastewater discharge[113]. - The company has established an emergency response plan for environmental incidents, filed with the local environmental protection bureau in December 2019, with registration number 3306822009066[117]. - The company donated 150,000 RMB to the charity association in Shaoxing during the reporting period, reflecting its commitment to social responsibility[123]. Risks and Challenges - The company faces risks including market growth not meeting expectations, high customer concentration, and fluctuations in exchange rates[6]. - The top five customers contributed to 49.77% of the company's sales revenue, indicating a high customer concentration risk[100]. - The company is facing potential risks from changes in tax incentives and foreign exchange fluctuations impacting its financial performance[104]. Corporate Governance - The company has a robust internal control system and governance structure to protect investor rights and ensure transparency in profit distribution[121]. - The company has not encountered any violations in the usage and management of raised funds, adhering to relevant laws and regulations[80]. - The company reported no significant related party transactions during the reporting period[135].
贝斯美(300796) - 2020 Q4 - 年度财报
2021-04-14 16:00
Financial Performance - The company reported a total revenue of 121,150,000 RMB for the year 2020, with a cash dividend of 0.5 RMB per 10 shares to all shareholders[6]. - The company's operating revenue for 2020 was ¥404,543,473.59, a decrease of 18.12% compared to ¥494,091,971.03 in 2019[18]. - The net profit attributable to shareholders for 2020 was ¥38,411,515.91, down 39.65% from ¥63,652,795.42 in 2019[18]. - The net profit after deducting non-recurring gains and losses was ¥34,734,808.17, a decline of 34.03% from ¥52,648,463.58 in 2019[18]. - The company achieved a total revenue of 405 million yuan and a net profit attributable to shareholders of 38.41 million yuan in 2020, reflecting a year-on-year revenue decline of 22.07% due to the impact of the COVID-19 pandemic[63]. - The company reported a significant increase in inventory for dimethyl sulfoxide raw materials, with a 607.03% rise in stock levels[83]. - The company reported a net profit margin of 12% for 2020, an increase from 10% in 2019, indicating improved operational efficiency[184]. Risks and Challenges - The company faces several risks including market growth below expectations, new product development risks, and high customer concentration risks[6]. - The company has a high customer concentration risk, which may impact its revenue stability[6]. - The company is facing risks related to market growth not meeting expectations due to global economic adjustments, which may impact agricultural production expansion[144]. Market and Product Development - The company plans to expand its market presence and enhance its product offerings through ongoing research and development initiatives[6]. - The global pesticide market is projected to reach $66.703 billion by 2023, with a compound annual growth rate of 3% from 2018 to 2023[27]. - The company aims to optimize its product structure by promoting high-efficiency, safe, and environmentally friendly new products, aligning with global trends towards sustainable agriculture[32]. - The company is focused on developing high-efficiency, low-toxicity, and low-residue environmentally friendly pesticide raw materials[69]. - The company is actively engaged in research and development of new products to maintain its market leadership[69]. Research and Development - Research and development investment amounted to 22.81 million yuan, accounting for 5.64% of total revenue, with a total of 51 patents granted by the end of 2020[64]. - The company holds 51 authorized patents, including 11 invention patents, and has established a provincial high-tech enterprise R&D center recognized by the Zhejiang Provincial Science and Technology Department[53]. - The company is investing 100 million CNY in R&D for new technologies aimed at improving production efficiency[172]. - The company plans to enhance its R&D capabilities and efficiency, focusing on product tiering and technological improvements to boost core competitiveness[142]. Cash Dividends and Profit Distribution - The company implemented a cash dividend policy, distributing 0.80 RMB per 10 shares, totaling 6,057,500 RMB, which represents 100% of the profit distribution amount[161]. - A cash dividend of CNY 0.5 per 10 shares (including tax) will be distributed, totaling CNY 6,057,500, with the remaining undistributed profit carried forward to the next year[165]. - The cash dividend for 2020 represents 15.77% of the net profit attributable to the parent company, which was CNY 38,411,515.91[167]. - The company has a profit distribution policy that prioritizes cash dividends, with a minimum cash dividend ratio of 20% for growth-stage companies with significant capital expenditure[157]. Strategic Initiatives - The company is actively expanding its domestic and international markets, enhancing its core competitiveness and maintaining long-term strategic partnerships with customers[65]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY allocated for potential mergers[171]. - The company plans to enhance its digital marketing strategy, aiming for a 30% increase in online sales channels by the end of 2021[186]. - The company is committed to ensuring the renewal of its safety production license and other relevant certifications[69]. Compliance and Governance - The company is focused on maintaining compliance with the regulations set forth for its IPO and subsequent market activities[181]. - The company has established measures to reduce or avoid unnecessary related party transactions, aiming for fair pricing and compliance with market principles[196]. - The company has outlined its commitment to transparency and accountability in its operations and shareholder relations[200]. Future Outlook - The company projects a revenue growth of 10% for the upcoming fiscal year, targeting 1.65 billion CNY[173]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next three years[175]. - Future guidance projects a revenue growth of 12% for 2021, driven by new product launches and market expansion[189].